6375-20-8

Basic information

• Product Name: N-(4-amino-3-methylphenyl)acetamide
• Synonyms: N-(4-amino-3-methylphenyl)acetamide;4-Acetylamino-o-toluidine;4'-Amino-3'-methylacetanilide;N-(4-amino-3-methylphenyl)acetamide(SALTDATA: FREE)
• CAS NO: 6375-20-8
• Molecular Formula: C₉H₁₂N₂O
• Molecular Weight: 164.20438
• Mol File: 6375-20-8.mol
• Article Data: 6

Chemical Properties

• Melting Point: 69-70.5 °C(Solv: water (7732-18-5))
• Boiling Point: 268.7°C at 760 mmHg
• Flash Point: 116.3°C
• Appearance: /
• Density: 1.163g/cm³
• Vapor Pressure: 0.00759mmHg at 25°C
• Refractive Index: 1.62
• PKA: 14.75±0.70(Predicted)
• CAS DataBase Reference: N-(4-amino-3-methylphenyl)acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(4-amino-3-methylphenyl)acetamide(6375-20-8)
• EPA Substance Registry System: N-(4-amino-3-methylphenyl)acetamide(6375-20-8)

Safety Data

• Hazardous Substances Data: 6375-20-8(Hazardous Substances Data)

Usage

InChI:InChI=1/C9H12N2O/c1-6-5-8(11-7(2)12)3-4-9(6)10/h3-5H,10H2,1-2H3,(H,11,12)

Upstream product

• 51366-39-3 4-acetamido-2-methylnitrobenzene 
• 108-24-7 acetic anhydride 
• 95-70-5 2-methyl-p-phenylenediamine 
• 95-80-7 4-methylbenzene-1,3-diamine 
• 106-50-3 1,4-phenylenediamine 
• 823-40-5 2,6-toluenediamine 
• 99584-85-7 3-methyl-4-nitro benzamide 
• 611-05-2 4-nitro-3-methylaniline 
• 99-52-5 2-methyl-4-nitro-benzenamine 
• 355809-03-9 2,2,2-trifluoro-N-(2-methyl-4-nitrophenyl)acetamide 

Downstream Products

• 102590-70-5 N-(7-methyl-2,3-diphenyl-indol-5-yl)-acetamide 
• 720699-25-2 acetic acid-(4-amino-5-methyl-2-nitro-anilide) 
• 25917-89-9 4-amino-3-nitro-6-methylaniline 
• 154150-99-9 N,N'-(2-methyl-5-nitro-p-phenylene)-bis-acetamide 
• 104479-02-9 C₁₄H₁₈N₄O₅ 

Relevant articles and documents

COMPOUNDS FOR INHIBITING TNIK AND MEDICAL USES THEREOF

The present disclosure provides the compound having inhibitory property against TNIK having a specific chemical structure or its pharmaceutically acceptable salt. The present disclosure also provides a composition comprising the compound or its pharmaceutically acceptable salt. The present disclosure also provides a medical use of the compound, its salt or the composition comprising the compound or its pharmaceutically acceptable salt for treating or preventing cancer. The present disclosure also provides a method of treatment or prevention of cancer comprising administering the compound, its salt or the composition comprising the compound or its salt to a subject in need of such treatment or prevention.

Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents

The present invention is directed to inhibitors of S-nitrosoglutathione reductase (GSNOR), pharmaceutical compositions comprising such GSNOR inhibitors, and methods of making and using the same.

2-[(Aminophenyl and amidophenyl)amino]-1-azacycloalkanes having antidiarrheal activity

This invention relates to the novel use of certain aromatic substituted amidines as antidiarrheals.